State
72,907 recalls have nationwide distribution and so reach Rhode Island. 3,043 additional recalls listed Rhode Island specifically in their distribution scope.
Of the 3,043 recalls naming Rhode Island we have scored against our rubric, 221 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 570 (19%) are Severe.
Which agencies issued them
These figures cover only the 3,043 recalls whose distribution notice names Rhode Island specifically. The 72,907 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Medtronic is recalling 288 units of the Octopus Evolution AS Tissue Stabilizer Model TS2500 due to incorrect tubing positioning during manufacturing, where short and long tubes were attached to wrong locations.
Zimmer is recalling the Off-Axis Comprehensive Shoulder System Small Reamer Guide due to plastic guides catching and breaking during reaming procedures.
Amgen, Inc. is recalling Sensipar (cinacalcet) 90mg tablets nationwide due to Current Good Manufacturing Practice (CGMP) deviations. The affected lot was distributed across the United States.
Elevate Oral Care is recalling Povi-One 10% Povidone-Iodine Oral Antiseptic nationwide due to sub potency. The affected lots have expiration dates ranging from June 2026 to October 2026.
Medline Industries is recalling convenience kits containing 10mL polycarbonate colored syringes due to unapproved design changes made outside of FDA clearance requirements.
PFM Medical Inc. is recalling Multi-Snare Set catheters (5 mm and 10 mm sizes) because they failed biocompatibility testing for in-vitro cytotoxicity and could cause localized inflammation and tissue irritation if they contact a patient's blood vessels.
Medtronic is recalling 590 units of the Octopus 4 Tissue Stabilizer, Model 29400 due to an assembly error where tubing was attached to the wrong positions during manufacturing.
Medline Industries is recalling convenience kits containing 10mL polycarbonate colored syringes due to unapproved design changes made outside FDA clearance. The affected kits have been distributed nationwide.
The Harvard Drug Group LLC is recalling METHYLERGONOVINE MALEATE Tablets 0.2 mg because the drug may be subpotent (contain less active ingredient than intended). The recall affects approximately 790 cartons distributed nationwide.
Direct Rx is recalling Duloxetine D/R 30 mg capsules (also sold as Cymbalta) distributed nationwide because the drug contains N-nitroso-duloxetine impurity above FDA-recommended interim limits.
Medline Industries is recalling convenience kits containing 10mL polycarbonate colored syringes because the products underwent unapproved design changes outside of FDA clearance.
Philips is recalling certain Avalon Fetal Monitor FM20 units worldwide due to incorrect speaker connector assembly that can cause device cables to be pulled out, leading to loss of speaker output.
Amgen Inc. is recalling Corlanor (ivabradine) 5 mg tablets nationwide due to the presence of a foreign substance. The recall affects approximately 934,577 bottles distributed in the United States.
Amgen is recalling specific lots of Corlanor (ivabradine) 7.5mg tablets nationwide due to the presence of a foreign substance. Patients should consult their healthcare provider before stopping this medication.
Medline Industries is recalling convenience kits containing 10mL polycarbonate colored syringes because the manufacturer made unapproved design changes not cleared by the FDA.
Medline Industries is recalling convenience kits containing 10mL polycarbonate colored syringes due to unapproved design changes made outside of FDA clearance. The affected kits were distributed nationwide.
ANI Pharmaceuticals is recalling Hydroxyzine Hydrochloride Oral Solution due to the presence of a foreign substance. The affected lot is S25133A, distributed nationwide.
Ford is recalling 2021-2023 Mustang Mach E vehicles because the rear differential pinion shaft may fracture, potentially causing loss of drive power or unintended movement.
Chrysler is recalling specific 2022-2024 Jeep models because a software error may cause the transmission gear selection indicator to fail to display.
Chrysler is recalling 2026 Jeep Grand Wagoneer and Grand Wagoneer L vehicles because brake software may disable stability control and brake assist, increasing crash risk.
Nissan is recalling specific JATCO automatic transmission assemblies because a hardware failure may cause the gear shifter indicator to display incorrectly, increasing crash risk.
Teko is recalling 2026 Triumph, Trophy, Trophy Plus, Turbo, and TurboLite vehicles because the acoustic vehicle alerting system may be missing, increasing pedestrian crash risk.
Nissan is recalling certain 2026 Rogue vehicles because the instrument panel may not display the transmission gear selection indicator, potentially leading to unintended vehicle movement or rollaway.
Jayco is recalling 2027 Entegra Accolade and Seneca motorhomes because missing front brackets allow the dinette to shift, increasing injury risk.
Ford is recalling 2024-2027 Lincoln Nautilus Hybrids and 2025-2027 Explorer Hybrids because a software error may prevent the pedestrian warning sound from playing.